Invasive aspergillosis in liver transplant recipients: Epidemiology, clinical characteristics, treatment, and outcomes in 116 cases
Invasive aspergillosis (IA) in liver transplant recipients is associated with grave outcomes. We reviewed 116 individual cases reported in the literature from 1985 to 2013. IA was diagnosed after a median of 25 days after transplantation and involved a single organ in 51% of the cases, whereas in th...
Saved in:
Published in | Liver transplantation Vol. 21; no. 2; pp. 204 - 212 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Wolters Kluwer Health, Inc
01.02.2015
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Invasive aspergillosis (IA) in liver transplant recipients is associated with grave outcomes. We reviewed 116 individual cases reported in the literature from 1985 to 2013. IA was diagnosed after a median of 25 days after transplantation and involved a single organ in 51% of the cases, whereas in the remaining cases, multiple sites were involved. The most common infecting Aspergillus species were Aspergillus fumigatus (73%), Aspergillus flavus (14%), and Aspergillus terreus (8%). Amphotericin B was the drug most frequently used, and it was followed by voriconazole and itraconazole. Combination regimens were used in 51% of the cases. The overall 1‐year cumulative survival probability was 35% [95% confidence interval (CI) = 24.6%‐49.6%]. Survival was significantly higher for patients reported from the year 2000 and thereafter (P < 0.001), for those diagnosed with IA more than 30 days after transplantation versus those diagnosed earlier (P = 0.019), and for patients without renal failure (P = 0.020). Additionally, the use of voriconazole was significantly associated with a higher probability of survival (P < 0.001). Cox regression analysis showed that subjects with the involvement of multiple sites had a 2.52 times higher risk of a negative outcome (95% CI = 1.08‐5.87) than those with the involvement of a single site. Thus, IA causes life‐threatening infections in liver transplant recipients. Predictors associated with poor outcomes may help clinicians to optimize the management of this infection. Liver Transpl 21:204‐212, 2015. © 2014 AASLD. |
---|---|
AbstractList | Invasive aspergillosis (IA) in liver transplant recipients is associated with grave outcomes. We reviewed 116 individual cases reported in the literature from 1985 to 2013. IA was diagnosed after a median of 25 days after transplantation and involved a single organ in 51% of the cases, whereas in the remaining cases, multiple sites were involved. The most common infecting
Aspergillus
species were
Aspergillus fumigatus
(73%),
Aspergillus flavus
(14%), and
Aspergillus terreus
(8%). Amphotericin B was the drug most frequently used, and it was followed by voriconazole and itraconazole. Combination regimens were used in 51% of the cases. The overall 1‐year cumulative survival probability was 35% [95% confidence interval (CI) = 24.6%‐49.6%]. Survival was significantly higher for patients reported from the year 2000 and thereafter (
P
< 0.001), for those diagnosed with IA more than 30 days after transplantation versus those diagnosed earlier (
P
= 0.019), and for patients without renal failure (
P
= 0.020). Additionally, the use of voriconazole was significantly associated with a higher probability of survival (
P
< 0.001). Cox regression analysis showed that subjects with the involvement of multiple sites had a 2.52 times higher risk of a negative outcome (95% CI = 1.08‐5.87) than those with the involvement of a single site. Thus, IA causes life‐threatening infections in liver transplant recipients. Predictors associated with poor outcomes may help clinicians to optimize the management of this infection.
Liver Transpl 21:204‐212, 2015
. © 2014 AASLD. Invasive aspergillosis (IA) in liver transplant recipients is associated with grave outcomes. We reviewed 116 individual cases reported in the literature from 1985 to 2013. IA was diagnosed after a median of 25 days after transplantation and involved a single organ in 51% of the cases, whereas in the remaining cases, multiple sites were involved. The most common infecting Aspergillus species were Aspergillus fumigatus (73%), Aspergillus flavus (14%), and Aspergillus terreus (8%). Amphotericin B was the drug most frequently used, and it was followed by voriconazole and itraconazole. Combination regimens were used in 51% of the cases. The overall 1‐year cumulative survival probability was 35% [95% confidence interval (CI) = 24.6%‐49.6%]. Survival was significantly higher for patients reported from the year 2000 and thereafter (P < 0.001), for those diagnosed with IA more than 30 days after transplantation versus those diagnosed earlier (P = 0.019), and for patients without renal failure (P = 0.020). Additionally, the use of voriconazole was significantly associated with a higher probability of survival (P < 0.001). Cox regression analysis showed that subjects with the involvement of multiple sites had a 2.52 times higher risk of a negative outcome (95% CI = 1.08‐5.87) than those with the involvement of a single site. Thus, IA causes life‐threatening infections in liver transplant recipients. Predictors associated with poor outcomes may help clinicians to optimize the management of this infection. Liver Transpl 21:204‐212, 2015. © 2014 AASLD. Invasive aspergillosis (IA) in liver transplant recipients is associated with grave outcomes. We reviewed 116 individual cases reported in the literature from 1985 to 2013. IA was diagnosed after a median of 25 days after transplantation and involved a single organ in 51% of the cases, whereas in the remaining cases, multiple sites were involved. The most common infecting Aspergillus species were Aspergillus fumigatus (73%), Aspergillus flavus (14%), and Aspergillus terreus (8%). Amphotericin B was the drug most frequently used, and it was followed by voriconazole and itraconazole. Combination regimens were used in 51% of the cases. The overall 1-year cumulative survival probability was 35% [95% confidence interval (CI) = 24.6%-49.6%]. Survival was significantly higher for patients reported from the year 2000 and thereafter (P < 0.001), for those diagnosed with IA more than 30 days after transplantation versus those diagnosed earlier (P = 0.019), and for patients without renal failure (P = 0.020). Additionally, the use of voriconazole was significantly associated with a higher probability of survival (P < 0.001). Cox regression analysis showed that subjects with the involvement of multiple sites had a 2.52 times higher risk of a negative outcome (95% CI = 1.08-5.87) than those with the involvement of a single site. Thus, IA causes life-threatening infections in liver transplant recipients. Predictors associated with poor outcomes may help clinicians to optimize the management of this infection. Invasive aspergillosis (IA) in liver transplant recipients is associated with grave outcomes. We reviewed 116 individual cases reported in the literature from 1985 to 2013. IA was diagnosed after a median of 25 days after transplantation and involved a single organ in 51% of the cases, whereas in the remaining cases, multiple sites were involved. The most common infecting Aspergillus species were Aspergillus fumigatus (73%), Aspergillus flavus (14%), and Aspergillus terreus (8%). Amphotericin B was the drug most frequently used, and it was followed by voriconazole and itraconazole. Combination regimens were used in 51% of the cases. The overall 1-year cumulative survival probability was 35% [95% confidence interval (CI) = 24.6%-49.6%]. Survival was significantly higher for patients reported from the year 2000 and thereafter (P < 0.001), for those diagnosed with IA more than 30 days after transplantation versus those diagnosed earlier (P = 0.019), and for patients without renal failure (P = 0.020). Additionally, the use of voriconazole was significantly associated with a higher probability of survival (P < 0.001). Cox regression analysis showed that subjects with the involvement of multiple sites had a 2.52 times higher risk of a negative outcome (95% CI = 1.08-5.87) than those with the involvement of a single site. Thus, IA causes life-threatening infections in liver transplant recipients. Predictors associated with poor outcomes may help clinicians to optimize the management of this infection.Invasive aspergillosis (IA) in liver transplant recipients is associated with grave outcomes. We reviewed 116 individual cases reported in the literature from 1985 to 2013. IA was diagnosed after a median of 25 days after transplantation and involved a single organ in 51% of the cases, whereas in the remaining cases, multiple sites were involved. The most common infecting Aspergillus species were Aspergillus fumigatus (73%), Aspergillus flavus (14%), and Aspergillus terreus (8%). Amphotericin B was the drug most frequently used, and it was followed by voriconazole and itraconazole. Combination regimens were used in 51% of the cases. The overall 1-year cumulative survival probability was 35% [95% confidence interval (CI) = 24.6%-49.6%]. Survival was significantly higher for patients reported from the year 2000 and thereafter (P < 0.001), for those diagnosed with IA more than 30 days after transplantation versus those diagnosed earlier (P = 0.019), and for patients without renal failure (P = 0.020). Additionally, the use of voriconazole was significantly associated with a higher probability of survival (P < 0.001). Cox regression analysis showed that subjects with the involvement of multiple sites had a 2.52 times higher risk of a negative outcome (95% CI = 1.08-5.87) than those with the involvement of a single site. Thus, IA causes life-threatening infections in liver transplant recipients. Predictors associated with poor outcomes may help clinicians to optimize the management of this infection. |
Author | Singh, Nina Barchiesi, Francesco Mazzocato, Susanna Skrami, Edlira Mazzanti, Sara Fiorentini, Alessandro Gesuita, Rosaria |
Author_xml | – sequence: 1 givenname: Francesco surname: Barchiesi fullname: Barchiesi, Francesco organization: Università Politecnica delle Marche – sequence: 2 givenname: Susanna surname: Mazzocato fullname: Mazzocato, Susanna organization: Università Politecnica delle Marche – sequence: 3 givenname: Sara surname: Mazzanti fullname: Mazzanti, Sara organization: Università Politecnica delle Marche – sequence: 4 givenname: Rosaria surname: Gesuita fullname: Gesuita, Rosaria organization: Polytechnic University of Marche – sequence: 5 givenname: Edlira surname: Skrami fullname: Skrami, Edlira organization: Polytechnic University of Marche – sequence: 6 givenname: Alessandro surname: Fiorentini fullname: Fiorentini, Alessandro organization: Università Politecnica delle Marche – sequence: 7 givenname: Nina surname: Singh fullname: Singh, Nina organization: VA Medical Center and University of Pittsburgh |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/25348192$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kcluFDEQhi0URBaQeAJkiQuH6cFrL9xQFCDSSFzC2fK4a0JFbrux3YnmzItjMkmQEJyqyvr-37WckqMQAxDymrM1Z0y892UtFJPiGTnhWnRNqzp59JS3-pic5nzDGOd6YC_IsdBS9XwQJ-TnZbi1GW-B2jxDukbvY8ZMMVBfXxMtyYY8exsKTeBwRgglf6AXM44wYfTxer-izmNAZz11322yrkDCXNDlVZWDLVPVrKgNI41LcXGCe3_OW-pshvySPN9Zn-HVQzwj3z5dXJ1_aTZfP1-ef9w0TtVJmqEbXMsGbnWN1spedJ2uJXd9u7Vy5IMCpWCww6CkYluxdb2EUegdl61jSp6RdwffOcUfC-RiJswOfB0O4pINb7VQoteyrejbv9CbuKRQu6uUqv9yxnWl3jxQy3aC0cwJJ5v25nG9FVgfAJdizgl2xmGxBWOoa0VvODO_72d8Mff3-9Pik-DR8x9oc0Dv0MP-v5zZXB34XwTPqBQ |
CODEN | LITRFO |
CitedBy_id | crossref_primary_10_6002_ect_2017_0171 crossref_primary_10_1089_sur_2023_346 crossref_primary_10_1016_j_ijantimicag_2015_05_023 crossref_primary_10_4254_wjh_v7_i14_1828 crossref_primary_10_1186_s12879_018_3617_4 crossref_primary_10_1097_MOT_0000000000000431 crossref_primary_10_1080_1744666X_2018_1476852 crossref_primary_10_1111_ctr_13544 crossref_primary_10_1002_micr_30137 crossref_primary_10_1007_s00595_021_02263_z crossref_primary_10_1016_j_mycmed_2022_101310 crossref_primary_10_15825_1995_1191_2024_3_56_65 crossref_primary_10_1016_j_anclin_2017_04_002 crossref_primary_10_1099_jmm_0_000233 crossref_primary_10_1111_tid_12898 crossref_primary_10_1111_myc_12469 crossref_primary_10_1080_14656566_2024_2326507 crossref_primary_10_1111_ajt_13837 crossref_primary_10_1016_j_jceh_2023_101316 crossref_primary_10_1177_0300060517729907 crossref_primary_10_1248_bpb_b18_00164 crossref_primary_10_3390_jof9020272 crossref_primary_10_1007_s12281_022_00446_w crossref_primary_10_1016_j_transproceed_2017_09_013 crossref_primary_10_1002_lt_24365 crossref_primary_10_1111_tid_14049 crossref_primary_10_5812_archcid_138411 crossref_primary_10_1186_s12893_019_0668_4 crossref_primary_10_1007_s00108_015_3807_8 crossref_primary_10_2174_1574886318666221206102653 crossref_primary_10_1007_s40588_015_0017_z crossref_primary_10_1186_s40792_021_01203_w crossref_primary_10_1016_j_cmi_2018_01_002 crossref_primary_10_3390_jof7070524 crossref_primary_10_1111_ajt_16935 crossref_primary_10_1007_s00606_016_1331_5 crossref_primary_10_1155_2015_960357 crossref_primary_10_1093_jac_dkz038 crossref_primary_10_1007_s10238_024_01419_8 crossref_primary_10_12998_wjcc_v6_i16_1155 crossref_primary_10_1002_micr_30272 crossref_primary_10_1080_1354750X_2020_1810318 crossref_primary_10_1016_j_mcna_2016_01_008 crossref_primary_10_3389_fimmu_2017_01273 crossref_primary_10_18499_2070_478X_2021_14_1_10_18 crossref_primary_10_3390_jof11010070 crossref_primary_10_7759_cureus_42554 crossref_primary_10_1016_j_gastre_2016_11_017 crossref_primary_10_1097_TP_0000000000004312 crossref_primary_10_1186_s12879_018_3527_5 crossref_primary_10_1007_s00428_025_04050_4 crossref_primary_10_1007_s12281_022_00442_0 crossref_primary_10_1097_GOX_0000000000002041 crossref_primary_10_1007_s00423_019_01769_y crossref_primary_10_1177_0885066618757410 crossref_primary_10_1097_TP_0000000000005082 crossref_primary_10_3390_jcm12093238 crossref_primary_10_3390_jof9020255 crossref_primary_10_1371_journal_pone_0197319 crossref_primary_10_3390_jcm12041520 crossref_primary_10_5812_jjm_104089 crossref_primary_10_1016_j_gastrohep_2016_11_011 crossref_primary_10_1097_HC9_0000000000000216 crossref_primary_10_2520_myco_65_109 crossref_primary_10_1016_j_jiac_2015_11_005 |
Cites_doi | 10.1093/clinids/13.4.653 10.1111/j.1399-3062.2011.00599.x 10.1182/blood-2007-01-069294 10.1053/jlts.2002.35778 10.1016/j.transproceed.2006.10.015 10.1016/j.transproceed.2007.10.013 10.1136/jcp.43.2.114 10.1093/jac/43.4.597 10.1016/S0168-8278(98)80329-2 10.1086/520297 10.1097/01.tp.0000263336.80146.27 10.1016/0732-8893(92)90074-4 10.1111/j.1399-3062.2004.00039.x 10.1086/525258 10.1378/chest.109.4.1119 10.1093/clinids/23.3.608 10.1212/WNL.42.9.1817 10.1016/S0190-9622(94)70169-5 10.1097/00005792-199903000-00003 10.1016/j.jinf.2012.08.003 10.1111/j.1399-3062.2009.00461.x 10.1093/jac/dkg450 10.1016/j.transproceed.2009.07.008 10.1016/j.transproceed.2004.09.043 10.1086/430602 10.1111/j.1399-3046.2007.00754.x 10.1086/596757 10.1007/BF02114892 10.1111/j.1432-2277.2008.00817.x 10.1111/j.1399-3062.2009.00367.x 10.1111/j.1439-0507.2009.01829.x 10.1086/345441 10.1097/00007890-199602270-00029 10.1016/j.healun.2013.11.003 10.1086/588660 10.1111/j.1399-3062.2008.00323.x 10.4161/viru.1.5.13110 10.1056/NEJMoa020191 10.1016/j.transproceed.2011.05.034 10.1111/ajt.12115 10.1016/j.transproceed.2007.05.085 10.1053/jlts.2002.36239 10.1097/00007890-199709150-00009 10.1111/1469-0691.12409 10.1136/jcp.48.3.210 10.1046/j.1439-0507.1999.00266.x 10.1097/00042737-200012010-00022 10.1097/01.tp.0000202421.94822.f7 10.1086/503427 10.1111/j.1399-3046.2008.00929.x 10.6002/ect.2012.0028 10.1592/phco.26.12.1730 10.1086/513655 10.1111/j.1399-0012.2008.00801.x 10.1016/j.jinf.2006.02.007 10.1093/infdis/166.6.1379 |
ContentType | Journal Article |
Copyright | 2014 American Association for the Study of Liver Diseases 2014 American Association for the Study of Liver Diseases. 2015 American Association for the Study of Liver Diseases |
Copyright_xml | – notice: 2014 American Association for the Study of Liver Diseases – notice: 2014 American Association for the Study of Liver Diseases. – notice: 2015 American Association for the Study of Liver Diseases |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM K9. 7X8 |
DOI | 10.1002/lt.24032 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE MEDLINE - Academic ProQuest Health & Medical Complete (Alumni) |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1527-6473 |
EndPage | 212 |
ExternalDocumentID | 3566976921 25348192 10_1002_lt_24032 LT24032 |
Genre | article Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- --K .3N .55 .GA .GJ .Y3 05W 0R~ 10A 1B1 1L6 1OC 1~5 24P 31~ 33P 3SF 3WU 4.4 4G. 4ZD 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5VS 7-5 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAEDT AAESR AAEVG AAHHS AALRI AAOCO AAONW AAQFI AAQXK AASGY AAXRX AAXUO AAZKR ABCQN ABCUV ABEML ABIJN ABJNI ABLJU ABMAC ABPVW ABWVN ABXGK ACAHQ ACCFJ ACCZN ACGFO ACGFS ACLDA ACMXC ACPOU ACRPL ACSCC ACXBN ACXQS ADEOM ADIZJ ADKYN ADMGS ADMUD ADNMO ADOZA ADXAS ADZMN AECAP AEEZP AEGXH AEIMD AENEX AEQDE AEUQT AFBPY AFGKR AFPWT AFUWQ AFZJQ AHMBA AIACR AIURR AIWBW AJAOE AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ATUGU AZBYB AZVAB BAFTC BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM DU5 E3Z EBS EJD F00 F01 F04 F5P FD6 FDB FEDTE FGOYB FUBAC G-S G.N GNP GODZA H.X HBH HF~ HHY HHZ HVGLF HZ~ IHE IX1 J0M J5H JPC KBYEO KQQ LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M41 MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NNB NQ- O66 O9- OIG OK1 OVD P2W P2X P2Z P4B P4D PQQKQ Q.N Q11 QB0 QRW R.K R2- RIG ROL RPZ RWI RX1 SEW SSZ SUPJJ TEORI UB1 UHS V2E V8K V9Y W8V W99 WBKPD WHWMO WIH WIJ WIK WIN WJL WOHZO WQJ WRC WVDHM WXI X7M XG1 XV2 ZZTAW ~IA ~WT AAFWJ AAYXX ACZKN AFNMH AGQPQ AHQVU CITATION MEWTI WXSBR ACIJW CGR CUY CVF ECM EIF NPM AAMMB ADSXY AEFGJ AGXDD AIDQK AIDYY K9. 7X8 |
ID | FETCH-LOGICAL-c4152-979c6091a59c6aa38277591a1c86ba3d194e44e9a994340b2bc83ed25f136c043 |
IEDL.DBID | DR2 |
ISSN | 1527-6465 1527-6473 |
IngestDate | Fri Jul 11 08:02:12 EDT 2025 Wed Aug 13 08:54:00 EDT 2025 Wed Feb 19 01:56:29 EST 2025 Tue Jul 01 00:48:28 EDT 2025 Thu Apr 24 22:53:47 EDT 2025 Wed Jan 22 16:57:55 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Language | English |
License | http://doi.wiley.com/10.1002/tdm_license_1.1 2014 American Association for the Study of Liver Diseases. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4152-979c6091a59c6aa38277591a1c86ba3d194e44e9a994340b2bc83ed25f136c043 |
Notes | This article is dedicated to Fausto Ancarani, M.D., 1950‐2011. Potential conflict of interest: Nina Singh has received investigator‐initiated research grant support from Pfizer and Astellas. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
PMID | 25348192 |
PQID | 1647751015 |
PQPubID | 1016400 |
PageCount | 9 |
ParticipantIDs | proquest_miscellaneous_1652428536 proquest_journals_1647751015 pubmed_primary_25348192 crossref_citationtrail_10_1002_lt_24032 crossref_primary_10_1002_lt_24032 wiley_primary_10_1002_lt_24032_LT24032 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | February 2015 |
PublicationDateYYYYMMDD | 2015-02-01 |
PublicationDate_xml | – month: 02 year: 2015 text: February 2015 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: Philadelphia |
PublicationTitle | Liver transplantation |
PublicationTitleAlternate | Liver Transpl |
PublicationYear | 2015 |
Publisher | Wolters Kluwer Health, Inc |
Publisher_xml | – name: Wolters Kluwer Health, Inc |
References | 2007; 39 2010; 12 1996; 109 2009; 41 1991; 13 1992; 166 2004; 6 1999; 43 2011; 54 1999; 42 2008; 105 2011; 13 1992; 15 2001; 44 2012; 125 2003; 52 2012; 10 2009; 48 2014; 20 2009; 11 1990; 43 2009; 13 2010; 1 2013; 2013 2013; 13 2000; 12 2004; 36 2006; 26 1996; 61 2002; 347 2008; 22 1992; 42 2012; 65 1996; 23 1994; 31 1998; 26 2009; 22 1998; 28 2006; 53 1997; 64 1995; 14 1997; 24 2002; 8 2003; 36 2005; 41 2008; 10 2007; 11 2006; 81 2006; 42 1995; 48 2007; 110 1999; 78 2008; 46 2011; 43 2007; 83 2008; 40 2014; 33 (lt24032-bib-0036-20240115) 2007; 39 (lt24032-bib-0040-20240115) 2008; 40 (lt24032-bib-0026-20240115) 1999; 42 (lt24032-bib-0037-20240115) 2008; 22 (lt24032-bib-0056-20240115) 2004; 36 (lt24032-bib-0028-20240115) 2001; 44 (lt24032-bib-0008-20240115) 1995; 14 (lt24032-bib-0001-20240115) 2013; 13 (lt24032-bib-0019-20240115) 1994; 31 (lt24032-bib-0044-20240115) 2009; 11 (lt24032-bib-0018-20240115) 1992; 42 (lt24032-bib-0030-20240115) 2002; 8 (lt24032-bib-0029-20240115) 2002; 8 (lt24032-bib-0027-20240115) 2000; 12 (lt24032-bib-0051-20240115) 2012; 125 (lt24032-bib-0006-20240115) 1996; 61 (lt24032-bib-0010-20240115) 1996; 23 (lt24032-bib-0032-20240115) 2006; 53 (lt24032-bib-0004-20240115) 2012; 65 (lt24032-bib-0012-20240115) 2002; 347 (lt24032-bib-0042-20240115) 2009; 22 (lt24032-bib-0015-20240115) 1990; 43 (lt24032-bib-0035-20240115) 2007; 83 (lt24032-bib-0002-20240115) 1997; 64 (lt24032-bib-0039-20240115) 2008; 105 (lt24032-bib-0054-20240115) 2006; 26 (lt24032-bib-0003-20240115) 2003; 36 (lt24032-bib-0034-20240115) 2007; 11 (lt24032-bib-0053-20240115) 2006; 42 (lt24032-bib-0052-20240115) 2013; 2013 (lt24032-bib-0060-20240115) 2014; 20 (lt24032-bib-0020-20240115) 1995; 48 (lt24032-bib-0043-20240115) 2009; 13 (lt24032-bib-0050-20240115) 2011; 43 (lt24032-bib-0058-20240115) 2009; 48 (lt24032-bib-0007-20240115) 2005; 41 (lt24032-bib-0033-20240115) 2007; 39 (lt24032-bib-0055-20240115) 2007; 110 (lt24032-bib-0025-20240115) 1999; 43 (lt24032-bib-0014-20240115) 2008; 46 (lt24032-bib-0045-20240115) 2011; 54 (lt24032-bib-0047-20240115) 2010; 12 (lt24032-bib-0057-20240115) 2008; 46 (lt24032-bib-0005-20240115) 1999; 78 (lt24032-bib-0013-20240115) 2006; 81 (lt24032-bib-0016-20240115) 1991; 13 (lt24032-bib-0009-20240115) 1992; 166 (lt24032-bib-0011-20240115) 2003; 52 (lt24032-bib-0038-20240115) 2008; 10 (lt24032-bib-0024-20240115) 1998; 26 (lt24032-bib-0023-20240115) 1998; 28 (lt24032-bib-0041-20240115) 2009; 41 (lt24032-bib-0021-20240115) 1996; 109 (lt24032-bib-0022-20240115) 1997; 24 (lt24032-bib-0049-20240115) 2011; 13 (lt24032-bib-0046-20240115) 2012; 10 (lt24032-bib-0031-20240115) 2004; 6 (lt24032-bib-0048-20240115) 2010; 1 (lt24032-bib-0017-20240115) 1992; 15 (lt24032-bib-0059-20240115) 2014; 33 |
References_xml | – volume: 13 start-page: 192 year: 2011 end-page: 199 article-title: vertebral osteomyelitis and ureteral obstruction after liver transplantation publication-title: Transpl Infect Dis – volume: 42 start-page: 1817 year: 1992 end-page: 1719 article-title: Treatment of cerebral aspergillosis after liver transplantation publication-title: Neurology – volume: 48 start-page: 503 year: 2009 end-page: 535 article-title: Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America publication-title: Clin Infect Dis – volume: 22 start-page: 508 year: 2008 end-page: 511 article-title: flavus myositis in a patient after liver transplantation publication-title: Clin Transplant – volume: 10 start-page: 333 year: 2008 end-page: 338 article-title: Real‐time PCR on the first galactomannan‐positive serum sample for diagnosis invasive aspergillosis in liver transplant recipients publication-title: Transpl Infect Dis – volume: 42 start-page: 1417 year: 2006 end-page: 1427 article-title: Diagnosis of invasive aspergillosis using a galactomannan assay: a meta‐analysis publication-title: Clin Infect Dis – volume: 65 start-page: 453 year: 2012 end-page: 464 article-title: Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry publication-title: J Infect – volume: 81 start-page: 320 year: 2006 end-page: 326 article-title: Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study publication-title: Transplantation – volume: 2013 start-page: 928289 year: 2013 article-title: tracheobronchitis causing subtotal tracheal stenosis in a liver transplant recipient publication-title: Case Rep Transplant – volume: 13 start-page: 228 year: 2013 end-page: 241 article-title: Aspergillosis in solid organ transplantation publication-title: Am J Transplant – volume: 64 start-page: 716 year: 1997 end-page: 720 article-title: Invasive aspergillosis in liver transplant recipients in the 1990s publication-title: Transplantation – volume: 10 start-page: 482 year: 2012 end-page: 486 article-title: Treatment of refractory cerebral aspergillosis in a liver transplant recipient with voriconazole: case report and review of the literature publication-title: Exp Clin Transplant – volume: 13 start-page: 636 year: 2009 end-page: 640 article-title: endocarditis in a pediatric liver transplant recipient: favorable outcome without cardiac surgery publication-title: Pediatr Transplant – volume: 23 start-page: 608 year: 1996 end-page: 615 article-title: Therapeutic outcome in invasive aspergillosis publication-title: Clin Infect Dis – volume: 125 start-page: 2772 year: 2012 end-page: 2774 article-title: Primary spondylodiscitis in a liver transplant recipient publication-title: Chin Med J (Engl) – volume: 43 start-page: 2428 year: 2011 end-page: 2430 article-title: Invasive pulmonary aspergillosis after living donor liver transplantation should be eradicated or not? A case report publication-title: Transplant Proc – volume: 43 start-page: 597 year: 1999 end-page: 600 article-title: Fungal infection and liposomal amphotericin B (AmBisome) therapy in liver transplantation: a 2 year review publication-title: J Antimicrob Chemother – volume: 11 start-page: 868 year: 2007 end-page: 875 article-title: Aspergillosis in children after liver transplantation: single center experience publication-title: Pediatr Transplant – volume: 28 start-page: 518 year: 1998 end-page: 522 article-title: Cerebral aspergillosis in a liver transplant recipient: a case report of long term survival after combined treatment with liposomal amphotericin B and surgery publication-title: J Hepatol – volume: 53 start-page: e231 year: 2006 end-page: e233 article-title: thyroiditis in a living donor liver transplant recipient publication-title: J Infect – volume: 26 start-page: 1092 year: 1998 end-page: 1097 article-title: Invasive pulmonary aspergillosis due to : 12‐year experience and review of the literature publication-title: Clin Infect Dis – volume: 24 start-page: 1172 year: 1997 end-page: 1177 article-title: Infectious ocular complications in orthotopic liver transplant patients publication-title: Clin Infect Dis – volume: 26 start-page: 1730 year: 2006 end-page: 1744 article-title: Factors influencing the magnitude and clinical significance of drug interactions between azole antifungals and select immunosuppressants publication-title: Pharmacotherapy – volume: 46 start-page: 327 year: 2008 end-page: 360 article-title: Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America publication-title: Clin Infect Dis – volume: 12 start-page: 51 year: 2010 end-page: 53 article-title: Severe cerebral aspergillosis after liver transplant publication-title: Transpl Infect Dis – volume: 42 start-page: 47 year: 1999 end-page: 53 article-title: Systemic mycoses during prophylactical use of liposomal amphotericin B (Ambisome) after liver transplantation publication-title: Mycoses – volume: 1 start-page: 465 year: 2010 end-page: 467 article-title: Successful, combined long‐term treatment of cerebral aspergillosis in a liver transplant patient publication-title: Virulence – volume: 12 start-page: 123 year: 2000 end-page: 126 article-title: osteomyelitis after liver transplantation: conservative or surgical treatment? publication-title: Eur J Gastroenterol Hepatol – volume: 110 start-page: 490 year: 2007 end-page: 500 article-title: Sirolimus‐based graft‐versus‐host disease prophylaxis protects against cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation: a cohort analysis publication-title: Blood – volume: 41 start-page: 52 year: 2005 end-page: 59 article-title: Risk factors for invasive aspergillosis in solid‐organ transplant recipients: a case‐control study publication-title: Clin Infect Dis – volume: 48 start-page: 210 year: 1995 end-page: 213 article-title: Use of the Pastorex antigen latex agglutination test for the diagnosis of invasive aspergillosis publication-title: J Clin Pathol – volume: 54 start-page: e220 year: 2011 end-page: e222 article-title: Invasive aspergillosis caused by in a living donor liver transplant recipient successfully treated by caspofungin publication-title: Mycoses – volume: 39 start-page: 3505 year: 2007 end-page: 3508 article-title: A case of successful resection after long‐term medical treatment of invasive pulmonary aspergillosis following living donor liver transplantation publication-title: Transplant Proc – volume: 11 start-page: 175 year: 2009 end-page: 178 article-title: Invasive aspergillosis in two liver transplant recipients: diagnosis by SeptiFast publication-title: Transpl Infect Dis – volume: 46 start-page: 1813 year: 2008 end-page: 1821 article-title: Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group publication-title: Clin Infect Dis – volume: 78 start-page: 123 year: 1999 end-page: 138 article-title: Invasive aspergillosis in transplant recipients publication-title: Medicine (Baltimore) – volume: 43 start-page: 114 year: 1990 end-page: 118 article-title: Cerebral aspergillosis in liver transplantation publication-title: J Clin Pathol – volume: 166 start-page: 1379 year: 1992 end-page: 1383 article-title: Factors associated with invasive lung aspergillosis and the significance of positive culture after liver transplantation publication-title: J Infect Dis – volume: 40 start-page: 1771 year: 2008 end-page: 1773 article-title: Hepatic and renal artery rupture due to and Mucor mixed infection after combined liver and kidney transplantation: a case report publication-title: Transplant Proc – volume: 36 start-page: 2708 year: 2004 end-page: 2709 article-title: Combined use of sirolimus and voriconazole in renal transplantation: a report of two cases publication-title: Transplant Proc – volume: 31 start-page: 344 year: 1994 end-page: 347 article-title: Primary cutaneous infection by in a 62‐year‐old liver transplant recipient publication-title: J Am Acad Dermatol – volume: 61 start-page: 666 year: 1996 end-page: 669 article-title: Incidence and significance of cultures following liver and kidney transplantation publication-title: Transplantation – volume: 109 start-page: 1119 year: 1996 end-page: 1124 article-title: Transmission of invasive aspergillosis from a subclinically infected donor to three different organ transplant recipients publication-title: Chest – volume: 52 start-page: 813 year: 2003 end-page: 819 article-title: Prevention of invasive fungal infections in liver transplant recipients: the role of prophylaxis with lipid formulations of amphotericin B in high‐risk patients publication-title: J Antimicrob Chemother – volume: 8 start-page: 1065 year: 2002 end-page: 1070 article-title: Risk factors for invasive aspergillosis in liver transplant recipients publication-title: Liver Transpl – volume: 39 start-page: 305 year: 2007 end-page: 307 article-title: Survival after disseminated invasive aspergillosis in a multivisceral transplant recipient publication-title: Transplant Proc – volume: 6 start-page: 37 year: 2004 end-page: 40 article-title: Deep sinus aspergillosis in a liver transplant recipient successfully treated with a combination of caspofungin and voriconazole publication-title: Transpl Infect Dis – volume: 15 start-page: 703 year: 1992 end-page: 706 article-title: Surgical wound infection by in liver transplant recipients publication-title: Diagn Microbiol Infect Dis – volume: 36 start-page: 46 year: 2003 end-page: 52 article-title: Trends in risk profiles for and mortality associated with invasive aspergillosis among liver transplant recipients publication-title: Clin Infect Dis – volume: 14 start-page: 375 year: 1995 end-page: 382 article-title: Risk factors for systemic fungal infections in liver transplant recipients publication-title: Eur J Clin Microbiol Infect Dis – volume: 20 start-page: 580 year: 2014 end-page: 585 article-title: Improvement in the outcome of invasive fusariosis in the last decade publication-title: Clin Microbiol Infect – volume: 13 start-page: 653 year: 1991 end-page: 657 article-title: Aspergillosis of the CNS in a pediatric liver transplant recipient: case report and review publication-title: Rev Infect Dis – volume: 22 start-page: 589 year: 2009 end-page: 591 article-title: Successful treatment of invasive sphenoidal, pulmonary and intracerebral aspergillosis after multivisceral transplantation publication-title: Transpl Int – volume: 8 start-page: 1073 year: 2002 end-page: 1075 article-title: osteomyelitis after liver transplantation publication-title: Liver Transpl – volume: 347 start-page: 408 year: 2002 end-page: 415 article-title: Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis publication-title: N Engl J Med – volume: 83 start-page: 1408 year: 2007 end-page: 1409 article-title: Successful treatment of invasive pulmonary aspergillosis after ABO‐incompatible living donor liver transplantation under rapid steroid withdrawal protocol publication-title: Transplantation – volume: 105 start-page: 66 year: 2008 end-page: 69 article-title: Severe endophthalmitis occurring after liver transplantation in an 8‐month‐old baby [in German] publication-title: Ophthalmologe – volume: 33 start-page: 278 year: 2014 end-page: 288 article-title: Invasive aspergillosis among heart transplant recipients: a 24‐year perspective publication-title: J Heart Lung Transplant – volume: 44 start-page: 370 issue: suppl year: 2001 end-page: 372 article-title: Coexistent cutaneous and cytomegalovirus infection in a liver transplant recipient publication-title: J Am Acad Dermatol – volume: 41 start-page: 2933 year: 2009 end-page: 2935 article-title: Endogenous endophthalmitis occurring after liver transplantation: a case report publication-title: Transplant Proc – volume: 13 start-page: 653 year: 1991 ident: lt24032-bib-0016-20240115 article-title: Aspergillosis of the CNS in a pediatric liver transplant recipient: case report and review publication-title: Rev Infect Dis doi: 10.1093/clinids/13.4.653 – volume: 13 start-page: 192 year: 2011 ident: lt24032-bib-0049-20240115 article-title: Aspergillus vertebral osteomyelitis and ureteral obstruction after liver transplantation publication-title: Transpl Infect Dis doi: 10.1111/j.1399-3062.2011.00599.x – volume: 110 start-page: 490 year: 2007 ident: lt24032-bib-0055-20240115 article-title: Sirolimus‐based graft‐versus‐host disease prophylaxis protects against cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation: a cohort analysis publication-title: Blood doi: 10.1182/blood-2007-01-069294 – volume: 8 start-page: 1073 year: 2002 ident: lt24032-bib-0029-20240115 article-title: Aspergillus osteomyelitis after liver transplantation publication-title: Liver Transpl doi: 10.1053/jlts.2002.35778 – volume: 39 start-page: 305 year: 2007 ident: lt24032-bib-0033-20240115 article-title: Survival after disseminated invasive aspergillosis in a multivisceral transplant recipient publication-title: Transplant Proc doi: 10.1016/j.transproceed.2006.10.015 – volume: 40 start-page: 1771 year: 2008 ident: lt24032-bib-0040-20240115 article-title: Hepatic and renal artery rupture due to Aspergillus and Mucor mixed infection after combined liver and kidney transplantation: a case report publication-title: Transplant Proc doi: 10.1016/j.transproceed.2007.10.013 – volume: 43 start-page: 114 year: 1990 ident: lt24032-bib-0015-20240115 article-title: Cerebral aspergillosis in liver transplantation publication-title: J Clin Pathol doi: 10.1136/jcp.43.2.114 – volume: 43 start-page: 597 year: 1999 ident: lt24032-bib-0025-20240115 article-title: Fungal infection and liposomal amphotericin B (AmBisome) therapy in liver transplantation: a 2 year review publication-title: J Antimicrob Chemother doi: 10.1093/jac/43.4.597 – volume: 28 start-page: 518 year: 1998 ident: lt24032-bib-0023-20240115 article-title: Cerebral aspergillosis in a liver transplant recipient: a case report of long term survival after combined treatment with liposomal amphotericin B and surgery publication-title: J Hepatol doi: 10.1016/S0168-8278(98)80329-2 – volume: 26 start-page: 1092 year: 1998 ident: lt24032-bib-0024-20240115 article-title: Invasive pulmonary aspergillosis due to Aspergillus terreus: 12‐year experience and review of the literature publication-title: Clin Infect Dis doi: 10.1086/520297 – volume: 83 start-page: 1408 year: 2007 ident: lt24032-bib-0035-20240115 article-title: Successful treatment of invasive pulmonary aspergillosis after ABO‐incompatible living donor liver transplantation under rapid steroid withdrawal protocol publication-title: Transplantation doi: 10.1097/01.tp.0000263336.80146.27 – volume: 15 start-page: 703 year: 1992 ident: lt24032-bib-0017-20240115 article-title: Surgical wound infection by Aspergillus fumigatus in liver transplant recipients publication-title: Diagn Microbiol Infect Dis doi: 10.1016/0732-8893(92)90074-4 – volume: 6 start-page: 37 year: 2004 ident: lt24032-bib-0031-20240115 article-title: Deep sinus aspergillosis in a liver transplant recipient successfully treated with a combination of caspofungin and voriconazole publication-title: Transpl Infect Dis doi: 10.1111/j.1399-3062.2004.00039.x – volume: 125 start-page: 2772 year: 2012 ident: lt24032-bib-0051-20240115 article-title: Primary Aspergillus spondylodiscitis in a liver transplant recipient publication-title: Chin Med J (Engl) – volume: 46 start-page: 327 year: 2008 ident: lt24032-bib-0057-20240115 article-title: Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America publication-title: Clin Infect Dis doi: 10.1086/525258 – volume: 109 start-page: 1119 year: 1996 ident: lt24032-bib-0021-20240115 article-title: Transmission of invasive aspergillosis from a subclinically infected donor to three different organ transplant recipients publication-title: Chest doi: 10.1378/chest.109.4.1119 – volume: 23 start-page: 608 year: 1996 ident: lt24032-bib-0010-20240115 article-title: Therapeutic outcome in invasive aspergillosis publication-title: Clin Infect Dis doi: 10.1093/clinids/23.3.608 – volume: 42 start-page: 1817 year: 1992 ident: lt24032-bib-0018-20240115 article-title: Treatment of cerebral aspergillosis after liver transplantation publication-title: Neurology doi: 10.1212/WNL.42.9.1817 – volume: 31 start-page: 344 year: 1994 ident: lt24032-bib-0019-20240115 article-title: Primary cutaneous infection by Aspergillus ustus in a 62‐year‐old liver transplant recipient publication-title: J Am Acad Dermatol doi: 10.1016/S0190-9622(94)70169-5 – volume: 78 start-page: 123 year: 1999 ident: lt24032-bib-0005-20240115 article-title: Invasive aspergillosis in transplant recipients publication-title: Medicine (Baltimore) doi: 10.1097/00005792-199903000-00003 – volume: 65 start-page: 453 year: 2012 ident: lt24032-bib-0004-20240115 article-title: Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry publication-title: J Infect doi: 10.1016/j.jinf.2012.08.003 – volume: 12 start-page: 51 year: 2010 ident: lt24032-bib-0047-20240115 article-title: Severe cerebral aspergillosis after liver transplant publication-title: Transpl Infect Dis doi: 10.1111/j.1399-3062.2009.00461.x – volume: 52 start-page: 813 year: 2003 ident: lt24032-bib-0011-20240115 article-title: Prevention of invasive fungal infections in liver transplant recipients: the role of prophylaxis with lipid formulations of amphotericin B in high‐risk patients publication-title: J Antimicrob Chemother doi: 10.1093/jac/dkg450 – volume: 41 start-page: 2933 year: 2009 ident: lt24032-bib-0041-20240115 article-title: Endogenous Aspergillus endophthalmitis occurring after liver transplantation: a case report publication-title: Transplant Proc doi: 10.1016/j.transproceed.2009.07.008 – volume: 36 start-page: 2708 year: 2004 ident: lt24032-bib-0056-20240115 article-title: Combined use of sirolimus and voriconazole in renal transplantation: a report of two cases publication-title: Transplant Proc doi: 10.1016/j.transproceed.2004.09.043 – volume: 41 start-page: 52 year: 2005 ident: lt24032-bib-0007-20240115 article-title: Risk factors for invasive aspergillosis in solid‐organ transplant recipients: a case‐control study publication-title: Clin Infect Dis doi: 10.1086/430602 – volume: 2013 start-page: 928289 year: 2013 ident: lt24032-bib-0052-20240115 article-title: Aspergillus tracheobronchitis causing subtotal tracheal stenosis in a liver transplant recipient publication-title: Case Rep Transplant – volume: 11 start-page: 868 year: 2007 ident: lt24032-bib-0034-20240115 article-title: Aspergillosis in children after liver transplantation: single center experience publication-title: Pediatr Transplant doi: 10.1111/j.1399-3046.2007.00754.x – volume: 48 start-page: 503 year: 2009 ident: lt24032-bib-0058-20240115 article-title: Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America publication-title: Clin Infect Dis doi: 10.1086/596757 – volume: 14 start-page: 375 year: 1995 ident: lt24032-bib-0008-20240115 article-title: Risk factors for systemic fungal infections in liver transplant recipients publication-title: Eur J Clin Microbiol Infect Dis doi: 10.1007/BF02114892 – volume: 44 start-page: 370 issue: suppl year: 2001 ident: lt24032-bib-0028-20240115 article-title: Coexistent cutaneous Aspergillus and cytomegalovirus infection in a liver transplant recipient publication-title: J Am Acad Dermatol – volume: 22 start-page: 589 year: 2009 ident: lt24032-bib-0042-20240115 article-title: Successful treatment of invasive sphenoidal, pulmonary and intracerebral aspergillosis after multivisceral transplantation publication-title: Transpl Int doi: 10.1111/j.1432-2277.2008.00817.x – volume: 11 start-page: 175 year: 2009 ident: lt24032-bib-0044-20240115 article-title: Invasive aspergillosis in two liver transplant recipients: diagnosis by SeptiFast publication-title: Transpl Infect Dis doi: 10.1111/j.1399-3062.2009.00367.x – volume: 54 start-page: e220 year: 2011 ident: lt24032-bib-0045-20240115 article-title: Invasive aspergillosis caused by Aspergillus terreus in a living donor liver transplant recipient successfully treated by caspofungin publication-title: Mycoses doi: 10.1111/j.1439-0507.2009.01829.x – volume: 36 start-page: 46 year: 2003 ident: lt24032-bib-0003-20240115 article-title: Trends in risk profiles for and mortality associated with invasive aspergillosis among liver transplant recipients publication-title: Clin Infect Dis doi: 10.1086/345441 – volume: 61 start-page: 666 year: 1996 ident: lt24032-bib-0006-20240115 article-title: Incidence and significance of Aspergillus cultures following liver and kidney transplantation publication-title: Transplantation doi: 10.1097/00007890-199602270-00029 – volume: 33 start-page: 278 year: 2014 ident: lt24032-bib-0059-20240115 article-title: Invasive aspergillosis among heart transplant recipients: a 24‐year perspective publication-title: J Heart Lung Transplant doi: 10.1016/j.healun.2013.11.003 – volume: 46 start-page: 1813 year: 2008 ident: lt24032-bib-0014-20240115 article-title: Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group publication-title: Clin Infect Dis doi: 10.1086/588660 – volume: 10 start-page: 333 year: 2008 ident: lt24032-bib-0038-20240115 article-title: Real‐time PCR on the first galactomannan‐positive serum sample for diagnosis invasive aspergillosis in liver transplant recipients publication-title: Transpl Infect Dis doi: 10.1111/j.1399-3062.2008.00323.x – volume: 1 start-page: 465 year: 2010 ident: lt24032-bib-0048-20240115 article-title: Successful, combined long‐term treatment of cerebral aspergillosis in a liver transplant patient publication-title: Virulence doi: 10.4161/viru.1.5.13110 – volume: 347 start-page: 408 year: 2002 ident: lt24032-bib-0012-20240115 article-title: Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis publication-title: N Engl J Med doi: 10.1056/NEJMoa020191 – volume: 43 start-page: 2428 year: 2011 ident: lt24032-bib-0050-20240115 article-title: Invasive pulmonary aspergillosis after living donor liver transplantation should be eradicated or not? A case report publication-title: Transplant Proc doi: 10.1016/j.transproceed.2011.05.034 – volume: 13 start-page: 228 year: 2013 ident: lt24032-bib-0001-20240115 article-title: Aspergillosis in solid organ transplantation publication-title: Am J Transplant doi: 10.1111/ajt.12115 – volume: 39 start-page: 3505 year: 2007 ident: lt24032-bib-0036-20240115 article-title: A case of successful resection after long‐term medical treatment of invasive pulmonary aspergillosis following living donor liver transplantation publication-title: Transplant Proc doi: 10.1016/j.transproceed.2007.05.085 – volume: 8 start-page: 1065 year: 2002 ident: lt24032-bib-0030-20240115 article-title: Risk factors for invasive aspergillosis in liver transplant recipients publication-title: Liver Transpl doi: 10.1053/jlts.2002.36239 – volume: 64 start-page: 716 year: 1997 ident: lt24032-bib-0002-20240115 article-title: Invasive aspergillosis in liver transplant recipients in the 1990s publication-title: Transplantation doi: 10.1097/00007890-199709150-00009 – volume: 20 start-page: 580 year: 2014 ident: lt24032-bib-0060-20240115 article-title: Improvement in the outcome of invasive fusariosis in the last decade publication-title: Clin Microbiol Infect doi: 10.1111/1469-0691.12409 – volume: 48 start-page: 210 year: 1995 ident: lt24032-bib-0020-20240115 article-title: Use of the Pastorex Aspergillus antigen latex agglutination test for the diagnosis of invasive aspergillosis publication-title: J Clin Pathol doi: 10.1136/jcp.48.3.210 – volume: 42 start-page: 47 year: 1999 ident: lt24032-bib-0026-20240115 article-title: Systemic mycoses during prophylactical use of liposomal amphotericin B (Ambisome) after liver transplantation publication-title: Mycoses doi: 10.1046/j.1439-0507.1999.00266.x – volume: 12 start-page: 123 year: 2000 ident: lt24032-bib-0027-20240115 article-title: Aspergillus osteomyelitis after liver transplantation: conservative or surgical treatment? publication-title: Eur J Gastroenterol Hepatol doi: 10.1097/00042737-200012010-00022 – volume: 81 start-page: 320 year: 2006 ident: lt24032-bib-0013-20240115 article-title: Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study publication-title: Transplantation doi: 10.1097/01.tp.0000202421.94822.f7 – volume: 42 start-page: 1417 year: 2006 ident: lt24032-bib-0053-20240115 article-title: Diagnosis of invasive aspergillosis using a galactomannan assay: a meta‐analysis publication-title: Clin Infect Dis doi: 10.1086/503427 – volume: 13 start-page: 636 year: 2009 ident: lt24032-bib-0043-20240115 article-title: Aspergillus fumigatus endocarditis in a pediatric liver transplant recipient: favorable outcome without cardiac surgery publication-title: Pediatr Transplant doi: 10.1111/j.1399-3046.2008.00929.x – volume: 10 start-page: 482 year: 2012 ident: lt24032-bib-0046-20240115 article-title: Treatment of refractory cerebral aspergillosis in a liver transplant recipient with voriconazole: case report and review of the literature publication-title: Exp Clin Transplant doi: 10.6002/ect.2012.0028 – volume: 26 start-page: 1730 year: 2006 ident: lt24032-bib-0054-20240115 article-title: Factors influencing the magnitude and clinical significance of drug interactions between azole antifungals and select immunosuppressants publication-title: Pharmacotherapy doi: 10.1592/phco.26.12.1730 – volume: 24 start-page: 1172 year: 1997 ident: lt24032-bib-0022-20240115 article-title: Infectious ocular complications in orthotopic liver transplant patients publication-title: Clin Infect Dis doi: 10.1086/513655 – volume: 22 start-page: 508 year: 2008 ident: lt24032-bib-0037-20240115 article-title: Aspergillus flavus myositis in a patient after liver transplantation publication-title: Clin Transplant doi: 10.1111/j.1399-0012.2008.00801.x – volume: 53 start-page: e231 year: 2006 ident: lt24032-bib-0032-20240115 article-title: Aspergillus thyroiditis in a living donor liver transplant recipient publication-title: J Infect doi: 10.1016/j.jinf.2006.02.007 – volume: 105 start-page: 66 year: 2008 ident: lt24032-bib-0039-20240115 article-title: Severe Aspergillus endophthalmitis occurring after liver transplantation in an 8‐month‐old baby [in German] publication-title: Ophthalmologe – volume: 166 start-page: 1379 year: 1992 ident: lt24032-bib-0009-20240115 article-title: Factors associated with invasive lung aspergillosis and the significance of positive Aspergillus culture after liver transplantation publication-title: J Infect Dis doi: 10.1093/infdis/166.6.1379 |
SSID | ssj0011590 |
Score | 2.3953228 |
Snippet | Invasive aspergillosis (IA) in liver transplant recipients is associated with grave outcomes. We reviewed 116 individual cases reported in the literature from... |
SourceID | proquest pubmed crossref wiley |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 204 |
SubjectTerms | Adult Amphotericin B - therapeutic use Aspergillosis - therapy Aspergillus flavus Aspergillus fumigatus Cohort Studies Female Humans Kaplan-Meier Estimate Liver Failure - complications Liver Failure - surgery Liver Transplantation Male Middle Aged Probability Proportional Hazards Models Renal Insufficiency - complications Transplant Recipients Treatment Outcome Voriconazole - therapeutic use |
Title | Invasive aspergillosis in liver transplant recipients: Epidemiology, clinical characteristics, treatment, and outcomes in 116 cases |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1002%2Flt.24032 https://www.ncbi.nlm.nih.gov/pubmed/25348192 https://www.proquest.com/docview/1647751015 https://www.proquest.com/docview/1652428536 |
Volume | 21 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT-MwELYQB8SFx7JAF1gZabV7aUqT2E7NDa1aAaJ7WLVSpT1EtuOgiihFmxQJrvxxZpwH6j4kxCmKMhk7Gc_4sz3-TMiXvkiFiDC7gTPtMZ5ITwsTeT63EtAEA1COA8XxD3E5ZdczPquzKnEvTMUP0U64oWe4eI0OrnRx9koampU95JLD8IupWoiHfrbMUYBz3PQKHtrqCSZ4wzvbD86aF1d7or_g5Spadd3NaJv8aipaZZnc9Zal7pmnPzgc3_clO2SrRqH0omo2u2TN5h_IxrheZ98jz1f5g8LEdqqQSfx2nmWLYl7QeU4zTOSgpeNEz8AsFOkx7nFXZXFOh6_nzT52abPrkppVVugubdPbu1TlCV0sS6izdfp9X1ADXWvxkUxHw8n3S68-rsEziAI8GUkjAH4oDlelwkEQRRxufTMQWoWJL5llzEolkZOurwNtBqFNAp6C_UyfhftkPV_k9pDQMDVpAjrDKIUIE4Q6GcDARyrDVMiV8DvkW2O62NRc5nikRhZXLMxBnJWx-6cdctpK3lf8Hf-QOW6sH9ceXMTIsxZhwOKgon0MvocLKiq3iyXKcEA4AHhEhxxUraYtJOC4xVmC8q_O9v8tPb6ZuOuntwoekU1AbbxKHT8m6-XvpT0BZFTqz84HXgDZQgfO |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5VrQRcWp7tlgJGQnDZbDfxI2s4IdRqC7s9oK3UA1LkOA5aEWWrJosEV_44M86jWh4S4hRFmdhOxmN_tme-AXgxVrlSMXk3SJEGQmY6SJWNg1A6jWhCICinheL8XE0vxPtLebkFb7pYmIYfot9wI8vw4zUZOG1IH9-whhb1iMjkcPzdoYTefj31seeOQqTjN1gobWugUKBjnh1Hx92bm3PRbwBzE6_6Ced0Dz51TW38TL6M1nU6st9_YXH8z2-5C7stEGVvm55zD7ZceR9uzduj9gfw46z8asi3nRkiE_-8LIpVtazYsmQF-XKw2tOiF6gZRgwZVxRYWb1mJzcpZ78NWRd4yewmMfSQ9R7uQ2bKjK3WNTba-fLDUDGLs2v1EC5OTxbvpkGbsSGwBAQCHWurEIEYiVdj-CSKY4m3oZ2o1PAs1MIJ4bTRREs3TqPUTrjLIpmHXNmx4I9gu1yV7gAYz22eYZk8znGQiXiaTXDto40VhkujwgG86nSX2JbOnLJqFElDxBwlRZ34fzqA573kVUPh8QeZo079SWvEVUJUazGNWRKL6B-j-dGZiindak0yEkEOYh41gP2m2_SVRJKinDUW_tIr_6-1J7OFvx7-q-AzuD1dzGfJ7Oz8w2O4gyBONp7kR7BdX6_dEwRKdfrUG8RPSlcL6Q |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1La9wwEBYlhdBL32k23bYKhPSy3rWth63eSjdLkiahlAQCORhZlsNS411ib6G99o93Rn6E7QNCTsZ4PJI9GumTNPqGkD1f5lJGGN0geOpxkSkvlSbyAmEVoAkOoBwniqdn8vCCH1-KyzaqEs_CNPwQ_YIbeobrr9HBl1k-uSUNLeoxcslB9_uQSz_GFj392lNHAdBx6yuYtdWTXIqOeNYPJ92b60PRX_hyHa668Wb2hFx1NW3CTL6NV3U6Nj__IHG836c8JY9bGEo_Nu3mGXlgy-dk87TdaH9Bfh2V3zVGtlONVOLX86JYVPOKzktaYCQHrR0pegF2ociPscRjldUHenCbcPbHiHbHLqlZp4Ue0T6-fUR1mdHFqoY6W6c_CCQ1MLZWL8nF7OD806HX5mvwDMIAT0XKSMAfWsBVaxaHUSTgNjCxTDXLAsUt51ZphaR0fhqmJmY2C0UeMGl8zrbIRrko7TahLDd5BjpZlEMXE7I0i2Hmo7ThmgktgwF535kuMS2ZOebUKJKGhjlMijpx_3RAdnvJZUPg8Q-ZYWf9pHXhKkGitQh7LAEq-sfgfLijoku7WKGMAIgDiEcOyKum1fSFhALPOCtQvu9s_9_Sk5Nzd925q-A7svllOktOjs4-vyaPAMGJJox8SDbqm5V9AyipTt86d_gNOw4KoQ |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Invasive+aspergillosis+in+liver+transplant+recipients%3A+epidemiology%2C+clinical+characteristics%2C+treatment%2C+and+outcomes+in+116+cases&rft.jtitle=Liver+transplantation&rft.au=Barchiesi%2C+Francesco&rft.au=Mazzocato%2C+Susanna&rft.au=Mazzanti%2C+Sara&rft.au=Gesuita%2C+Rosaria&rft.date=2015-02-01&rft.issn=1527-6473&rft.eissn=1527-6473&rft.volume=21&rft.issue=2&rft.spage=204&rft_id=info:doi/10.1002%2Flt.24032&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1527-6465&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1527-6465&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1527-6465&client=summon |